Premium Reports
Drug Diversion Monitoring 2019

Drug Diversion Monitoring 2019
An Early Look at Emerging vs. Established Technology

Authored by: Jackson Tate and Paul Warburton August 20, 2019 | Read Time: 3  minutes

Current Time Inside Cache Tag Helper: 2/24/2021 1:36:33 PM and Model.reportId = 1570

Given the increased nationwide focus on the opioid epidemic, there has been a surge in demand for advanced drug diversion monitoring tools. Both established and emerging vendors have responded by developing new solutions that promise next-generation technology to comprehensively and proactively monitor dispensing behaviors. This report offers an early look at how far along these vendors are and what the customer experience is like so far. Despite increased interest, few customers feel they are having a true next-generation experience with their solution today.

Healthcare Providers,
Want to see full details?

Not a Provider, contact us for pricing details.

Current Time Inside Cache Tag Helper: 2/24/2021 1:36:33 PM and Model.reportId = 1570

Key Findings

  1. Omnicell Analytics: Most-Adopted Emerging Solution, but Many Hamstrung without EMR Integration
  2. Most Medacist RxAuditor Customers Dissatisfied with Manual Investigation Workflows
  3. Kit Check (Limited Data) Shows Early Signs of Consistent Next-Gen Experience and Improved Accuracy
  4. Emerging Solutions Still Vying for Purchase Energy
 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2021 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.